Table: begin end state 1 32 non-cytoplasmic 33 53 transmembrane 54 59 cytoplasmic 60 82 transmembrane 83 99 non-cytoplasmic 100 121 transmembrane 122 129 cytoplasmic 130 152 transmembrane 153 173 non-cytoplasmic 174 199 transmembrane 200 210 cytoplasmic 211 232 transmembrane 233 276 non-cytoplasmic 277 300 transmembrane 301 319 cytoplasmic 320 340 transmembrane 341 346 non-cytoplasmic 347 368 transmembrane 369 369 cytoplasmic 370 388 transmembrane 389 407 non-cytoplasmic 408 438 transmembrane 439 559 cytoplasmic
Input: >BWI76_RS17465 MNRLFSSHVMPFRALIDACWKEKYTASRFTRDVIAGITVGIIAIPLAMALAIGSGVAPQY GLYTSAVAGIVIALTGGSRFSVSGPTAAFVVILYPVSQQFGLAGLLVATLMSGIFLILFG LARFGRLIEYIPLSVTLGFTSGIGITIGTMQIKDFLGLQMAHVPEHYLQKVGALAMALPT INPGDAAIGVVTLGTLIIWPRLGIRLPGHLPALLAGCAVMGVVNLLGGHVATIGSQFHYI LADGSQGNGIPQLLPQLVLPWDMPGSDFTLSWSSLQALLPAAFSMAMLGAIESLLCAVVL DGMTGTKHKANSELIGQGLGNIVAPFFGGITATAAIARSAANVRAGATSPVSAVIHALLV IMALLVLAPLLSWLPLSAMAALLLMVAWNMSEAHKVVNLLRYAPKDDIIVMLMCMSLTVL FDMVIAISVGIVLASLLFMRRIARMTRLAPVNVEVPDDVLVLRVIGPLFFAAAEGLFTDL ETRVAGKRIVVLKWDAVPVLDAGGLDAFQRFVKKLPEGCELRVSNLEFQPLRTLARAGVK PIPGRLSFYPDRNAALADI
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server